Paper6721990
Pharmacokinetics of primaquine in man: identification of the carboxylic acid derivative as a major plasma metabolite.
Mihaly GW and 4 others. Br J Clin Pharmacol, 1984. Cited by 138 papers, by iCite.
Cite this record
ConductScience Library. Pharmacokinetics of primaquine in man: identification of the carboxylic acid derivative as a major plasma metabolite. Papers, record 6721990. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6721990
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pharmacokinetics of primaquine in man: identification of the carboxylic acid derivative as a major plasma metabolite.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Primaquine | Major topic |
| Adult | |
| Biotransformation | |
| Half-Life | |
| Humans | |
| Kinetics | |
| Male | |
| Middle Aged |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT02898779 | Metabolism and Pharmacokinetics of Primaquine Enantiomers in Human Volunteers, Study 1 | Results |
Source ClinicalTrials.gov
References7
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 813015 | The search for new antimalarial drugs. | J Trop Med Hyg | 1975 | https://conductscience.org/library/papers/813015 | PubMed |
| 2 | 498695 | Naphthoxylactic acid after single and long-term doses of propranolol. | Clin Pharmacol Ther | 1979 | https://conductscience.org/library/papers/498695 | PubMed |
| 3 | 6934796 | Plasma kinetics and urinary excretion of primaquine in man. | Br J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/6934796 | PubMed |
| 4 | 6707149 | Determination of primaquine in biological fluids by reversed-phase high-performance liquid chromatography. | J Chromatogr | 1984 | https://conductscience.org/library/papers/6707149 | PubMed |
| 5 | 7107769 | High-performance liquid chromatographic analysis of the metabolism of primaquine and the identification of a new mammalian metabolite. | J Chromatogr | 1982 | https://conductscience.org/library/papers/7107769 | PubMed |
| 6 | 6827469 | Microbial metabolism studies on the major microbial and mammalian metabolite of primaquine. | J Pharm Sci | 1983 | https://conductscience.org/library/papers/6827469 | PubMed |
| 7 | 6976849 | Metabolism of 8-aminoquinoline antimalarial agents. | Bull World Health Organ | 1981 | https://conductscience.org/library/papers/6976849 | PubMed |
Cited by71
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 138 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41320957 | Humanization of Drug Metabolism in the Plasmodium berghei Mouse Model for Antimalarial Drug Discovery. | ACS Infect Dis | 2025 | https://conductscience.org/library/papers/41320957 | PubMed |
| 41028863 | Enhancing CYP2D6 genotyping with nanopore sequencing to address allele diversity P. vivax malaria elimination. | Sci Rep | 2025 | https://conductscience.org/library/papers/41028863 | PubMed |
| 39334094 | Addressing health equity for breastfeeding women: primaquine for Plasmodium vivax radical cure. | Malar J | 2024 | https://conductscience.org/library/papers/39334094 | PubMed |
| 38840151 | Bioequivalence of a new coated 15 mg primaquine formulation for malaria elimination. | Malar J | 2024 | https://conductscience.org/library/papers/38840151 | PubMed |
| 36726785 | Comparative metabolism and tolerability of racemic primaquine and its enantiomers in human volunteers during 7-day administration. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36726785 | PubMed |
| 35709685 | Comparative single dose pharmacokinetics and metabolism of racemic primaquine and its enantiomers in human volunteers. | Drug Metab Pharmacokinet | 2022 | https://conductscience.org/library/papers/35709685 | PubMed |
| 35659684 | Simultaneous and enantiospecific quantification of primaquine and carboxyprimaquine in human plasma using liquid chromatography-tandem mass spectrometry. | Malar J | 2022 | https://conductscience.org/library/papers/35659684 | PubMed |
| 35648190 | Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions. | Arch Toxicol | 2022 | https://conductscience.org/library/papers/35648190 | PubMed |
| 35123453 | Comparative pharmacokinetics and tissue distribution of primaquine enantiomers in mice. | Malar J | 2022 | https://conductscience.org/library/papers/35123453 | PubMed |
| 34978892 | Measurements of 5,6-Orthoquinone, a Surrogate for the Presumed Active Primaquine Metabolite 5-Hydroxyprimaquine, in the Urine of Cambodian Adults. | Antimicrob Agents Chemother | 2022 | https://conductscience.org/library/papers/34978892 | PubMed |
| 34299634 | Simplified and Rapid Determination of Primaquine and 5,6-Orthoquinone Primaquine by UHPLC-MS/MS: Its Application to a Pharmacokinetic Study. | Molecules | 2021 | https://conductscience.org/library/papers/34299634 | PubMed |
| 34063671 | Population Pharmacokinetics of Primaquine in the Korean Population. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/34063671 | PubMed |
| 33673562 | Synthesis, Biological Activity and In Silico Pharmacokinetic Prediction of a New 2-Thioxo-Imidazoldidin-4-One of Primaquine. | Pharmaceuticals (Basel) | 2021 | https://conductscience.org/library/papers/33673562 | PubMed |
| 32705964 | Doses of primaquine administered to children with Plasmodium vivax according to an age-based dose regimen. | Pathog Glob Health | 2020 | https://conductscience.org/library/papers/32705964 | PubMed |
| 31898492 | An in vitro toolbox to accelerate anti-malarial drug discovery and development. | Malar J | 2020 | https://conductscience.org/library/papers/31898492 | PubMed |
| 31366609 | 8-Aminoquinoline Therapy for Latent Malaria. | Clin Microbiol Rev | 2019 | https://conductscience.org/library/papers/31366609 | PubMed |
| 31031463 | Population pharmacokinetics of primaquine and the effect of hepatic and renal dysfunction: An exploratory approach. | Indian J Pharmacol | 2019 | https://conductscience.org/library/papers/31031463 | PubMed |
| 30700282 | Formation primaquine-5,6-orthoquinone, the putative active and toxic metabolite of primaquine via direct oxidation in human erythrocytes. | Malar J | 2019 | https://conductscience.org/library/papers/30700282 | PubMed |
| 30442143 | Real time PCR detection of common CYP2D6 genetic variants and its application in a Karen population study. | Malar J | 2018 | https://conductscience.org/library/papers/30442143 | PubMed |
| 30379233 | Levels of primaquine and carboxyprimaquine in patients with malaria vivax from the Brazilian Amazon basin. | Rev Inst Med Trop Sao Paulo | 2018 | https://conductscience.org/library/papers/30379233 | PubMed |
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| PRIMAQUINE | CHEMBL506 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL506 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Genes
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6721990
GET https://conductscience.org/api/papers/v1/6721990/cited_by?page=2